[Primary open-angle glaucoma]
- PMID: 30594326
- DOI: 10.1016/j.revmed.2018.12.001
[Primary open-angle glaucoma]
Abstract
Primary open-angle glaucoma is a progressive chronic optic neuropathy, typically bilateral, that occurs after the age of 40 years. It is the second leading cause of irreversible blindness in the world. Primary open-angle glaucoma corresponds to a progressive loss of retinal ganglion cell characterized by an excavation of the optic disc associated with typical visual field defects. Elevated intraocular pressure is the main risk factor of primary open-angle glaucoma. Diagnosis and monitoring of primary open-angle glaucoma arebased on both analysis of structural alteration, by clinical examination of optic disc completed by imaging tests (Ocular Coherence Tomography), and functional alterations, by visual field tests. The only effective treatment to slow primary open-angle glaucoma progression is the reduction of the intraocular pressure with anti-glaucomatous eye drops, laser or surgical treatments.
Keywords: Anti-glaucomatous treatment; Champ visuel; Collyres anti-glaucomateux; Glaucome primitif à angle ouvert; Neuropathie optique; Ocular coherence tomography (OCT); Ocular coherence tomography OCT; Optic neuropathy; Primary open-angle glaucoma; Visual field.
Copyright © 2018 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.Ophthalmology. 2008 Feb;115(2):239-245.e2. doi: 10.1016/j.ophtha.2007.03.086. Ophthalmology. 2008. PMID: 18082888
-
Potential of stratus optical coherence tomography for detecting early glaucoma in perimetrically normal eyes of open-angle glaucoma patients with unilateral visual field loss.J Glaucoma. 2010 Jan;19(1):61-5. doi: 10.1097/IJG.0b013e31819c486b. J Glaucoma. 2010. PMID: 20075675
-
Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study.Ophthalmology. 2000 Sep;107(9):1702-9. doi: 10.1016/s0161-6420(00)00275-x. Ophthalmology. 2000. PMID: 10964833
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.Int Ophthalmol. 2019 Jan;39(1):259-271. doi: 10.1007/s10792-017-0795-9. Epub 2017 Dec 30. Int Ophthalmol. 2019. PMID: 29290065 Review.
Cited by
-
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.Biomedicines. 2021 Dec 31;10(1):89. doi: 10.3390/biomedicines10010089. Biomedicines. 2021. PMID: 35052769 Free PMC article.
-
Cannabinoid-Based Ocular Therapies and Formulations.Pharmaceutics. 2023 Mar 27;15(4):1077. doi: 10.3390/pharmaceutics15041077. Pharmaceutics. 2023. PMID: 37111563 Free PMC article. Review.
-
Glaucoma suspects referred by general ophthalmologists to a tertiary center in Brazil: outcomes of the glaucoma specialist assessment.Arq Bras Oftalmol. 2023 May-Jun;86(3):248-254. doi: 10.5935/0004-2749.20230029. Arq Bras Oftalmol. 2023. PMID: 35417521 Free PMC article.
-
Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions.Pharmaceuticals (Basel). 2023 Jul 24;16(7):1052. doi: 10.3390/ph16071052. Pharmaceuticals (Basel). 2023. PMID: 37513963 Free PMC article. Review.
-
PBX1 attenuates H2O2-induced oxidant stress in human trabecular meshwork cells via promoting NANOG-mediated PI3K/AKT signaling pathway.Cell Stress Chaperones. 2022 Nov;27(6):673-684. doi: 10.1007/s12192-022-01304-x. Epub 2022 Oct 18. Cell Stress Chaperones. 2022. PMID: 36253638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources